6520sek
0,3 %
Date:2024-04-24Time:13:24:36Latest report:Q1-2024List:Mid CapTicker:LINC
Market Cap:3 770 msekEnterprise Value:3 269 msekNet Sales:- msekEarnings:401,0 msekEmployees:0ISIN:SE0015949433

Ratios

10-year key figure history for Linc turnover, profit, dividend, equity, PE and PB.

Pre
Pre

Stockprice

Price movement for Linc with index and moving average MA50 and MA200.

Stockprice:65,20
MA50:63,69
MA200:62,41
Price/MA200:4,3 %
RSI (14):63,5
Price/MA50:2,2 %

Description

Linc is an investment company with a focus on long-term shareholding in the Nordic life science market. The company invests in and mainly develops small and medium-sized product-oriented life science companies in the medical technology and pharmaceutical industry. Investments are made in both private and public companies and in research and business companies. Typically, investments in pharmaceutical companies take place in an earlier phase compared with investments in medical technology companies. Linc is an active and long-term owner with a broad industrial network to support the portfolio companies and their development.

Holding Companies